About
Nabla builds a unified clinical AI platform for healthcare organizations, including ambient documentation, dictation, coding, and agentic workflow tools embedded in EHR systems. Its differentiation is contextual, secure clinical AI designed for real-world practice across specialties, languages, care settings, and provider roles.
Market
Nabla competes in the ambient clinical AI and healthcare documentation market, positioning its product as a Clinical AI Layer embedded in Epic and other major EHRs. Its differentiation is the combination of ambient note generation, real-time dictation, coding support, clinical suggestions, multilingual capabilities, and clinical-grade speech recognition aimed at enterprise health-system deployment.
Nabla primarily serves enterprise healthcare-provider organizations—health systems, hospitals, and multi-site clinics—that want to reduce documentation burden and improve clinical workflows. Its users are clinicians, while likely buying stakeholders include clinical and health-IT leadership responsible for EHR and documentation operations.
At a Glance
Problem
Nabla addresses the administrative and cognitive load of clinical documentation: clinicians must listen, synthesize, format notes, and complete coding while maintaining a patient relationship. The pain is also economic: screen-based documentation competes with attention during the encounter and consumes scarce clinician time and capacity. The killer use case is an ambient assistant that captures the patient-clinician conversation and turns it into a structured note, reducing the need to type throughout the visit. Because documentation also feeds coding and final code submission, improving this workflow can support greater efficiency, although the available research does not quantify the savings.
Product / Service
Nabla provides a clinical-intelligence layer embedded in existing EHR workflows. Its ambient documentation product captures the clinical conversation and automatically generates structured notes, while its dictation capability provides clinical-grade speech recognition inside Epic and other major EHRs. The platform is designed to support care before, during, and after the visit rather than functioning only as a note-taking tool.
The offering has expanded into coding suggestions grounded in clinical documentation and AMA guidelines, broader clinical workflow tools, and agentic AI for multi-step clinical and administrative tasks. Nabla positions the product as enterprise-grade infrastructure for secure deployment across health systems, with clinicians retaining control over final coding decisions. The benefit is a faster, more flexible documentation process that lets clinicians focus more on patients while reducing manual work.
Market
Nabla competes in the ambient clinical intelligence and AI medical-scribe market, with a broader position in clinical workflow automation. The most prominent direct competitors identified in the research are Abridge, Ambience Healthcare, and Suki; Microsoft-owned Nuance is a major adjacent incumbent in the same category. The market is crowded and expected to consolidate as health systems choose among ambient documentation and broader clinical AI platforms.
Nabla is commercial and not pre-revenue. The latest disclosed operating figures in the research, from June 2025, report fivefold revenue growth over the preceding six months, more than 85,000 clinicians supported, 20 million annual encounters, and adoption across more than 130 healthcare organizations. Those figures indicate substantial enterprise traction, although the available evidence does not provide audited revenue, profitability, or a newer 2026 operating update.
Founders & Leadership
Funding History
Artemis Health
Cathay Innovation
HV Capital, Highland Europe
Recent News
Nabla announced Nabla Dictation for Mac, a fully on-device clinical dictation app built natively for macOS. It combines on-device speech recognition with deep Epic integration and supports existing PowerMic and SpeechMike hardware.
Nabla appointed Brian Manning as CEO to lead its next phase of commercial and enterprise growth. Co-founder Alex LeBrun moved to Executive Chairman and Chief AI Officer, while the rest of the leadership team remained in place.
Nabla announced a partnership with University of Toledo Health to deploy AI-powered clinical documentation to hundreds of physicians and advanced practice providers. The health system reported a 29% reduction in time to chart closure during an eight-week evaluation and expanded the deployment.
Nabla reported that its partner Advanced Machine Intelligence raised $1.03 billion to accelerate development of world-model AI systems. The funding is relevant to Nabla because its exclusive partnership with AMI gives Nabla first access to the emerging technology for healthcare applications.
M Health Fairview selected Nabla's combined Ambient AI Assistant and Dictation solution for systemwide deployment. The announcement highlighted early improvements in documentation completeness, workflow efficiency, and usability across multiple specialties.
Aultman Health System implemented Nabla natively within Oracle Cerner across inpatient and outpatient settings. The integration was completed in under 60 days, and early results showed clinicians saving 30 to 60 minutes per day on documentation.
Nabla announced an exclusive strategic partnership with Advanced Machine Intelligence, founded by Yann LeCun, providing Nabla with first access to AMI's emerging world-model technologies. The companies described the partnership as a foundation for more reliable, deterministic, and potentially FDA-certifiable agentic healthcare AI.
Nabla launched Nabla Connect, a plug-and-play module enabling EHR vendors to offer ambient AI without building the capability in-house. The offering supports more than 55 specialties and 35 languages and is designed to be HIPAA- and GDPR-compliant, SOC 2 Type 2 certified, and ISO 27001 certified.
Nabla announced that more than 30 provider groups had integrated its ambient AI assistant through the athenahealth Marketplace during the first year. The announcement positioned the athenahealth integration as part of Nabla's broader strategy across more than 15 major EHR platforms.
Nabla announced its addition to Epic Toolbox for Ambient Voice Recognition, enabling deployment directly through Epic's Haiku mobile app. Clinicians can use Nabla within Epic workflows without downloading or signing into a separate application.
Active Roles
15Business Model
Nabla appears to monetize its clinical AI software through commercial healthcare-organization and per-clinician arrangements. Public pricing is not officially published; third-party market evidence estimates approximately $119 per clinician per month, while Nabla sells into health systems and provider groups.
Products
Customers
Tech Stack
Similar Companies
Competitors
Key Investors
HV Capital, Highland Europe, Cathay Innovation